News

Investigators asked the children’s parents about the history of musculoskeletal-related disease, observed the children’s gait, and performed physical examinations.

To determine the association between infertility and fertility treatment with ASD risk, investigators conducted a retrospective, population-based study using health data from Ontario, Canada.

The study authors wrote that future work could prioritize data from late summer and early fall seasons to better ascertain lead time values.

Continuous glucose monitors have been found to improve sleep for parents of young children with type 1 diabetes and may help alleviate the care burden associated with the condition, according to a study conducted in France.

In this Contemporary Pediatrics interview, Lawrence Eichenfield, MD, explains additional challenges pediatric atopic dermatitis patients face during winter months and colder weather.

Investigators concluded that pharmacists at the pediatric HSSP performed clinical interventions beyond their daily clinical and operational activities, based on results from a study presented at the Health-System Pharmacists Midyear Clinical Meeting & Exhibition held in Anaheim, California, from December 3, 2023, to December 7, 2023.

In a poster abstract presented at the American Society of Health-System Pharmacists Midyear Clinical Meeting & Exhibition held in Anaheim, California, stress ulcer prophylaxis (SUP) did not appear to provide benefit for prevention of gastrointestinal bleeding and did not increase SUP-associated adverse effects.

Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

According to the American Academy of Pediatrics (AAP), it is recommended that 45% to 65% of total daily calories come from carbohydrates, though very low-carbohydrate diets allow for 20 to 50 grams per day.

In the almost 10 years of data collected by the research team, nearly 1.5 million antiviral medications were dispensed to pediatric patients, and oseltamivir accounted for 99.8% of those prescriptions.

Lawrence Eichenfield, MD, reacts to the FDA's acceptance of a supplemental New Drug Application for roflumilast cream 0.15% to treat atopic dermatitis (AD) in patients aged 6 years and older.

The reaction, called Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), can start as a rash but can progress quickly, potentially resulting in injury to internal organs, hospitalization, and death. 

The FDA has accepted a supplemental New Drug Application (sNDA) for roflumilast cream 0.15% for the treatment of atopic dermatitis (AD) in children aged 6 years and up.

Yamo Pharmaceuticals has initiated a phase 3 readiness program for L1-79, following the enrollment of its final patient in a phase 2 study evaluating the autism spectrum disorder (ASD) treatment for patients aged 2 to 21 years.

The FDA granted Priority Review to pz-cel following a phase 1/2 and a pivotal phase 3 study in which the treatment for recessive dystrophic epidermolysis bullosa (RDEB) demonstrated wound healing and pain reduction.

The 2022-2023 influenza season was the fourth season to be classified as high severity since the 2009 influenza A(H1N1) pandemic. 

Understanding the knowledge about the structure of the family and its respective support system can play a role in determining and recognizing each family’s needs.

Of patients in the atopic dermatitis (AD) cohort, 36.6% developed at least 1 comorbidity amid follow-up compared to 28.5% in the non-AD reference cohort, investigators of a Sweden, nationwide, population-based cohort study found.

A recent study underscores the significant disease burden in children with sickle cell disease, urging consideration for earlier and higher-dose hydroxyurea treatment to alleviate morbidity, especially in those with HbSS/Sβ0 thalassemia.

Once a food is accepted, similarly colored, textured, or flavored foods can be used in addition, expanding the number of items the child might eat.

Studies have shown that gratitude has led to improved sleep quality and has decreased symptoms of unexplained aches and pains, according to healthychildren.org.

The Fast Track Designation follows the recent announcement of phase 1/2 data from the Harmony trial.

The warning letters issued to 7 manufacturers are part of a larger, on-going effort by the FDA to address manufacturing, distribution, and sale of illegal and unauthorized e-cigarettes.

Overall, the study authors concluded that the immunogenicity of QIV and TIV was similar for common influenza ingredients for children aged 6 to 35 months.

CDC recommends HCV testing in these populations as a critical step to achieving national priority of eliminating HCV.

Despite efforts to enhance communication between clinics and community groups, a study finds no significant improvement in parental knowledge and attitudes toward HPV vaccination during children's primary care visits, highlighting the persistent challenge of low vaccine uptake in the United States.

Age-appropriate diabetes support for students is detailed, encompassing legal frameworks, healthcare plans, and the essential role of school health teams in effective school management.

Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

The US approval makes VLA1553 (Ixchiq; Valneva) the world’s first licensed chikungunya vaccine.

This decision makes Owlet’s Dream Sock the first and only over-the-counter medical-grade pulse oximeter that is cleared for use in infants, according to the company.